Posts in Investor relations

by gene001web
September 1, 2023

GeneTether Therapeutics Inc. Announces Second Quarter 2023 Financial Results

Vancouver, British Columbia – August 25, 2023
0
read more
by gene001web
May 2, 2023

GeneTether Therapeutics Inc. Announces Fiscal Year 2022 Financial Results and Reports on Corporate Highlights

Vancouver, British Columbia – April 27, 2023
0
read more
by gene001web
March 31, 2023

GeneTether Therapeutics Inc. Update – From the Desk of the CEO

Vancouver, British Columbia – March 30, 2023
0
read more
by gene001web
November 29, 2022

GeneTether Therapeutics Inc. Announces Third Quarter 2022 Financial Results and Reports on Corporate Highlights

Vancouver, British Columbia – November 25, 2022
0
read more
by gene001web
August 25, 2022

GeneTether Therapeutics Inc. Announces Second Quarter 2022 Financial Results and Reports on Corporate Highlights

Vancouver, British Columbia – August 24, 2022
0
read more
by gene001web
May 27, 2022

GeneTether Therapeutics Inc. Announces First Quarter 2022 Financial Results and Reports on Corporate Highlights

Vancouver, British Columbia – May 26, 2022
0
read more
by gene001web
May 9, 2022

GeneTether Therapeutics Inc. Announces Fiscal Year 2021 Financial Results and Reports on Corporate Highlights

Vancouver, British Columbia – April 28, 2022
0
read more
by gene001web
March 29, 2022

GeneTether Therapeutics Completes Initial Public Offering and Announces Listing on the Canadian Securities Exchange

Kelowna, British Columbia – March 29, 2022
0
read more
by gene001web
March 22, 2022

GeneTether Therapeutics Inc. Files Final Prospectus for Initial Public Offering of Units

Vancouver, British Columbia – March 22, 2022
0
read more
by gene001web
March 14, 2022

GeneTether Therapeutics Inc. Receives Notice of Allowance from USPTO

Vancouver, British Columbia – February 14, 2022
0
read more